EWA
PRAX icon

EverSource Wealth Advisors’s Praxis Precision Medicines PRAX Stock Holding History

EverSource Wealth Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Sell
30
-20
-40% -$6.33K ﹤0.01% 2910
2026
Q1 		$16.1K Buy
50
+25
+100% +$7.73K ﹤0.01% 2637
2025
Q4 		$7.37K Buy
25
+7
+39% +$1.3K ﹤0.01% 2945
2025
Q3 		$954 Hold
18
– – ﹤0.01% 3773
2025
Q2 		$757 Buy
18
+7
+64% +$267 ﹤0.01% 3799
2025
Q1 		$417 Buy
+11
New +$687 ﹤0.01% 3519

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

EverSource Wealth Advisors's PRAX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Praxis Precision Medicines (PRAX) stake by 40% in Q2 2026, selling an estimated $6.33K and leaving 30 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2910.

EverSource Wealth Advisors first reported a position in PRAX in Q1 2025 and has held it in 6 quarters since. The position peaked at $16.1K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • EverSource Wealth Advisors held 30 shares of Praxis Precision Medicines worth $10K as of Q2 2026.
  • EverSource Wealth Advisors sold 20 Praxis Precision Medicines shares in Q2 2026, an estimated $6.33K.
  • Praxis Precision Medicines made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2910 holding.
  • EverSource Wealth Advisors first reported a position in Praxis Precision Medicines in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Praxis Precision Medicines position peaked at $16.1K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.